Medicamen Biotech Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 473.2 million compared to INR 386.65 million a year ago. Revenue was INR 478.86 million compared to INR 390.12 million a year ago.

Net income was INR 20.4 million compared to INR 37.69 million a year ago. Basic earnings per share from continuing operations was INR 1.61 compared to INR 3.03 a year ago. Diluted earnings per share from continuing operations was INR 1.61 compared to INR 3.03 a year ago.